Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera

被引：274

作者：

Muik, Alexander ^{[1
]}

Lui, Bonny Gaby ^{[1
]}

Wallisch, Ann-Kathrin ^{[1
]}

Bacher, Maren ^{[1
]}

Muehl, Julia ^{[1
]}

Reinholz, Jonas ^{[1
]}

Ozhelvaci, Orkun ^{[1
]}

Beckmann, Nina ^{[1
]}

Garcia, Ramon de la Caridad Gueimil ^{[1
]}

Poran, Asaf ^{[2
]}

Shpyro, Svetlana ^{[1
]}

Finlayson, Andrew ^{[1
]}

Cai, Hui ^{[3
]}

Yang, Qi ^{[3
]}

Swanson, Kena A. ^{[3
]}

Tuereci, Oezlem ^{[1
,4
]}

Sahin, Ugur ^{[1
,5
]}

机构：

[1] BioNTech, Goldgrube 12, D-55131 Mainz, Germany

[2] BioNTech US, 40 Erie St, Cambridge, MA 02139 USA

[3] Pfizer, 401 N Middletown Rd, Pearl River, NY 10960 USA

[4] HITRON Helmholtz Inst Translat Oncol Mainz DKFZ, Obere Zahlbacherstr 63, D-55131 Mainz, Germany

[5] Johannes Gutenberg Univ Mainz, TRON gGmbH Translat Oncol, Univ Med Ctr, Freiligrathstr 12, D-55131 Mainz, Germany

来源：

SCIENCE | 2022年 / 375卷 / 6581期

关键词：

ANTIBODY;

D O I：

10.1126/science.abn7591

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The globally circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern Omicron (B.1.1.529) has a large number of mutations, especially in the spike protein, indicating that recognition by neutralizing antibodies may be compromised. We tested Wuhan (Wuhan-Hu-1 reference strain), Beta (B.1.351), Delta (B.1.617.2), or Omicron pseudoviruses with sera of 51 participants who received two or three doses of the messenger RNA (mRNA)-based COVID-19 vaccine BNT162b2. After two doses, Omicron-neutralizing titers were reduced >22-fold compared with Wuhan-neutralizing titers. One month after the third vaccine dose, Omicron-neutralizing titers were increased 23-fold relative to their levels after two doses and were similar to levels of Wuhan-neutralizing titers after two doses. The requirement of a third vaccine dose to effectively neutralize Omicron was confirmed with sera from a subset of participants using live SARS-CoV-2. These data suggest that three doses of the mRNA vaccine BNT162b2 may protect against Omicron-mediated COVID-19.

引用

页码：678 / +

页数：25

共 28 条

[1] Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
Abu-Raddad, Laith J.
Chemaitelly, Hiam
Butt, Adeel A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02) : 187 - 189
[2] SARS-CoV-2-specific T cells in infection and vaccination
Bertoletti, Antonio
Le Bert, Nina
Qui, Martin
Tan, Anthony T.
[J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (10) : 2307 - 2312
[3] Case James Brett, 2020, Cell Host Microbe, V28, P475, DOI [10.1101/2020.05.18.102038, 10.1016/j.chom.2020.06.021]
[4] Cele Sandile, 2021, medRxiv, DOI [10.1101/2021.12.08.21267417, 10.1101/2021.12.08.21267417]
[5] SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
Falsey, Ann R.
Frenck, Robert W., Jr.
Walsh, Edward E.
Kitchin, Nicholas
Absalon, Judith
Gurtman, Alejandra
Lockhart, Stephen
Bailey, Ruth
Swanson, Kena A.
Xu, Xia
Koury, Kenneth
Kalina, Warren
Cooper, David
Zou, Jing
Xie, Xuping
Xia, Hongjie
Tuereci, Ozlem
Lagkadinou, Eleni
Tompkins, Kristin R.
Shi, Pei-Yong
Jansen, Kathrin U.
Sahin, Ugur
Dormitzer, Philip R.
Gruber, William C.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17) : 1627 - 1629
[6] Ferguson N., Report 49: Growth, DOI [DOI 10.25561/93038, 10.25561/93038]
[7] Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Greaney, Allison J.
Starr, Tyler N.
Gilchuk, Pavlo
Zost, Seth J.
Binshtein, Elad
Loes, Andrea N.
Hilton, Sarah K.
Huddleston, John
Eguia, Rachel
Crawford, Katharine H. D.
Dingens, Adam S.
Nargi, Rachel S.
Sutton, Rachel E.
Suryadevara, Naveenchandra
Rothlauf, Paul W.
Liu, Zhuoming
Whelan, Sean P. J.
Carnahan, Robert H.
Crowe, James E., Jr.
Bloom, Jesse D.
[J]. CELL HOST & MICROBE, 2021, 29 (01) : 44 - +
[8] Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals
Grunau, Brian
Goldfarb, DavidM.
Asamoah-Boaheng, Michael
Golding, Liam
Kirkham, Tracy L.
Demers, Paul A.
Lavoie, Pascal M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (03): : 279 - 281
[9] SARS-CoV-2 variants, spike mutations and immune escape
Harvey, William T.
Carabelli, Alessandro M.
Jackson, Ben
Gupta, Ravindra K.
Thomson, Emma C.
Harrison, Ewan M.
Ludden, Catherine
Reeve, Richard
Rambaut, Andrew
Peacock, Sharon J.
Robertson, David L.
[J]. NATURE REVIEWS MICROBIOLOGY, 2021, 19 (07) : 409 - 424
[10] Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
Khoury, David S.
Cromer, Deborah
Reynaldi, Arnold
Schlub, Timothy E.
Wheatley, Adam K.
Juno, Jennifer A.
Subbarao, Kanta
Kent, Stephen J.
Triccas, James A.
Davenport, Miles P.
[J]. NATURE MEDICINE, 2021, 27 (07) : 1205 - +

← 1 2 3 →